FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005376880> ?p ?o ?g. }

• W2005376880 endingPage "31" @default.
• W2005376880 startingPage "23" @default.
• W2005376880 abstract "Eleven patients entered a double-blind, cross-over study that compared the influence of a new transdermal preparation of nitroglycerin (Nitrodisc: MDD-NG, Searle Limited) on exercise performance with the influence of placebo. Eight patients have completed the study. All patients had severe stable angina, and ten had angiographically proven, severe, three-vessel coro nary disease (including two patients with left main stem disease). Ejection fraction varied between 0.31 and 0.74. No patient received beta-blocking drugs or calcium antagonists at the time of entry into the study. All patients initially underwent a series of maximal treadmill exercise tests according to a modified Bruce Protocol. After a base-line exercise test, the active device was titrated to the point of efficacy or until side effects occurred. In stage 2 the patients were randomly allocated to an active or placebo group during the course of which further exercise tests were performed at two hours and 26 hours after the application of the device. In stage 3 the patients' regimens were crossed-over after one day's rest to the treatment they had not received in the first treatment period. Further exercise tests were performed at two hours and 26 hours after application of the preparation. Three days after the last 26-hour test, a further exercise test was run to determine the stability of the base-line. Three patients were removed from the study: two as a result of the appear ance of unstable angina requiring urgent coronary surgery; the third patient died from non-cardiac causes during the titration stage of the study. The mean duration of exercise at the pre-study exercise test was 11.9 minutes. Two hours after the application of MDD-NG, the mean duration of exercise increased to 14.4 minutes compared with 11.3 minutes with placebo ( P<.05). This effect was maintained at 26 hours with a mean duration of exercise of 14.1 minutes with MDD-NG compared with 11.8 minutes with placebo (P< .05). This repre sents a 30% increase in exercise capacity from base-line at two hours and 25% at 26 hours for the active drug. Exercise times to anginal threshhold associated with 1.5 mm of ST segment depression were increased by 38% at two hours after the application of MDD-NG when compared with control and was 44% at 26 hours after the application. These differences were statistically significant (P<.05). Changes in the double product of heart rate and systolic blood pressure at peak exercise were not significantly different between control, active drug, or placebo. Changes in the consumption of oral nitroglycerin were assessed during the titration phase on the active drug. From the fourth day onward the consumption of nitroglycerin was reduced by 63%. Side effects, including headache and blurring of vision, occurred in two patients; these responded readily to a reduction in dosage. It is concluded from these preliminary data that MDD-NG significantly increases exercise capacity in patients with stable angina and that this effect is maintained during a 24-hour period using a single-dose application." @default.
• W2005376880 created "2016-06-24" @default.
• W2005376880 creator A5029666739 @default.
• W2005376880 date "1983-01-01" @default.
• W2005376880 modified "2023-10-06" @default.
• W2005376880 title "The Clinical Use of Transdermal Delivery Devices with Nitroglycerin" @default.
• W2005376880 cites W1586573123 @default.
• W2005376880 cites W1963718765 @default.
• W2005376880 cites W1964222405 @default.
• W2005376880 cites W1975092445 @default.
• W2005376880 cites W1992749724 @default.
• W2005376880 cites W1992880946 @default.
• W2005376880 cites W1996972928 @default.
• W2005376880 cites W1999167094 @default.
• W2005376880 cites W2008312058 @default.
• W2005376880 cites W2049601033 @default.
• W2005376880 cites W2062657356 @default.
• W2005376880 cites W2142653656 @default.
• W2005376880 cites W2163718944 @default.
• W2005376880 cites W4293430741 @default.
• W2005376880 doi "https://doi.org/10.1177/000331978303400103" @default.
• W2005376880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6401952" @default.
• W2005376880 hasPublicationYear "1983" @default.
• W2005376880 type Work @default.
• W2005376880 sameAs 2005376880 @default.
• W2005376880 citedByCount "75" @default.
• W2005376880 crossrefType "journal-article" @default.
• W2005376880 hasAuthorship W2005376880A5029666739 @default.
• W2005376880 hasConcept C126322002 @default.
• W2005376880 hasConcept C130049864 @default.
• W2005376880 hasConcept C141071460 @default.
• W2005376880 hasConcept C142724271 @default.
• W2005376880 hasConcept C204787440 @default.
• W2005376880 hasConcept C205679159 @default.
• W2005376880 hasConcept C27081682 @default.
• W2005376880 hasConcept C2777953023 @default.
• W2005376880 hasConcept C2778198053 @default.
• W2005376880 hasConcept C2778425758 @default.
• W2005376880 hasConcept C2781464450 @default.
• W2005376880 hasConcept C42219234 @default.
• W2005376880 hasConcept C500558357 @default.
• W2005376880 hasConcept C71924100 @default.
• W2005376880 hasConcept C78085059 @default.
• W2005376880 hasConcept C84393581 @default.
• W2005376880 hasConcept C98274493 @default.
• W2005376880 hasConceptScore W2005376880C126322002 @default.
• W2005376880 hasConceptScore W2005376880C130049864 @default.
• W2005376880 hasConceptScore W2005376880C141071460 @default.
• W2005376880 hasConceptScore W2005376880C142724271 @default.
• W2005376880 hasConceptScore W2005376880C204787440 @default.
• W2005376880 hasConceptScore W2005376880C205679159 @default.
• W2005376880 hasConceptScore W2005376880C27081682 @default.
• W2005376880 hasConceptScore W2005376880C2777953023 @default.
• W2005376880 hasConceptScore W2005376880C2778198053 @default.
• W2005376880 hasConceptScore W2005376880C2778425758 @default.
• W2005376880 hasConceptScore W2005376880C2781464450 @default.
• W2005376880 hasConceptScore W2005376880C42219234 @default.
• W2005376880 hasConceptScore W2005376880C500558357 @default.
• W2005376880 hasConceptScore W2005376880C71924100 @default.
• W2005376880 hasConceptScore W2005376880C78085059 @default.
• W2005376880 hasConceptScore W2005376880C84393581 @default.
• W2005376880 hasConceptScore W2005376880C98274493 @default.
• W2005376880 hasIssue "1" @default.
• W2005376880 hasLocation W20053768801 @default.
• W2005376880 hasLocation W20053768802 @default.
• W2005376880 hasOpenAccess W2005376880 @default.
• W2005376880 hasPrimaryLocation W20053768801 @default.
• W2005376880 hasRelatedWork W1998059932 @default.
• W2005376880 hasRelatedWork W2017945832 @default.
• W2005376880 hasRelatedWork W2073714788 @default.
• W2005376880 hasRelatedWork W2088483014 @default.
• W2005376880 hasRelatedWork W2227654656 @default.
• W2005376880 hasRelatedWork W2312949019 @default.
• W2005376880 hasRelatedWork W2379084044 @default.
• W2005376880 hasRelatedWork W2514373213 @default.
• W2005376880 hasRelatedWork W3141623075 @default.
• W2005376880 hasRelatedWork W2086124389 @default.
• W2005376880 hasVolume "34" @default.
• W2005376880 isParatext "false" @default.
• W2005376880 isRetracted "false" @default.
• W2005376880 magId "2005376880" @default.
• W2005376880 workType "article" @default.